These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22693259)

  • 1. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRAS mutant melanoma: Towards better therapies.
    Randic T; Kozar I; Margue C; Utikal J; Kreis S
    Cancer Treat Rev; 2021 Sep; 99():102238. PubMed ID: 34098219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in the pathogenesis of malignant melanoma.
    Glud M; Gniadecki R
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):142-50. PubMed ID: 22621697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
    Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
    Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
    Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
    Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-mediated regulation of melanoma.
    Sun V; Zhou WB; Majid S; Kashani-Sabet M; Dar AA
    Br J Dermatol; 2014 Aug; 171(2):234-41. PubMed ID: 24665835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
    J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
    Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
    Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Biology and Genetic Mechanisms in the Progression of the Malignant Skin Melanoma.
    Pejkova S; Dzokic G; Tudzarova-Gjorgova S; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2016 Nov; 37(2-3):89-97. PubMed ID: 27883322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
    Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
    Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
    Mishra RR; Kneitz S; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in cancer: lessons from melanoma.
    Greenberg E; Nemlich Y; Markel G
    Curr Pharm Des; 2014; 20(33):5246-59. PubMed ID: 24479804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review.
    Poniewierska-Baran A; Zadroga Ł; Danilyan E; Małkowska P; Niedźwiedzka-Rystwej P; Pawlik A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.